| Patent Number |
Title Of Patent |
Date Issued |
| 4492685 |
Protective skin matrix |
January 8, 1985 |
| A protective skin matrix is provided which is particularly suited for the protection of burned or wounded patients. The matrix may be either cured, applied in sheets, or painted or sprayed directly onto the burned or wounded patient. The protective skin matrix includes polyvinylpyrrolido |
| 4472372 |
Polymeric diffusion matrix containing chlorpheniramine maleate |
September 18, 1984 |
| There is disclosed a polymeric diffusion matrix for the sustained release of chlorpheniramine maleate by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of chlorphenira |
| 4470962 |
Polymeric diffusion matrix |
September 11, 1984 |
| A polymeric diffusion matrix is provided comprising from about 2 to about 60% glycerol, from about 2 to about 15% polyvinylalcohol, from about 2 to about 10% water soluble polymer with hydration sites which in combination with the remaining ingredients yields a matrix capable of sustaine |
| 4466953 |
Polymeric diffusion matrix |
August 21, 1984 |
| A polymeric diffusion matrix is provided comprising from about 2 to about 60% glycerol, from about 2 to about 15% polyvinylalcohol, from about 2 to about 10% water soluble polymer with hydration sites which in combination with the remaining ingredients yields a matrix capable of sustaine |
| 4460562 |
Polymeric diffusion matrix containing propranolol |
July 17, 1984 |
| A self-supporting polymeric diffusion matrix provides for the sustained release of propranolol in order to deliver the propranolol to a patient. The matrix comprises from about 1 to about 60% of a polar plasticizer, from about 6 to about 30% by weight polyvinylalcohol, from about 2 to |
| 4438139 |
Polymeric diffusion matrix containing estrogens |
March 20, 1984 |
| A polymeric diffusion matrix for the sustained release, intravaginal administration of an estrogen is provided. The matrix consists of polyvinylalcohol, polyvinylpyrrolidone and a polar plasticizer. |
| 4321252 |
Polymeric diffusion matrix containing ester derivatives of estradiol |
March 23, 1982 |
| There is disclosed a polymeric diffusion matrix for the sustained release of an estradiol ester by delivery to a patient requiring uterine wall maintenance or other types of estrogen therapy wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and |
| 4294820 |
Polymeric diffusion matrix containing phenylephrine |
October 13, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of phenylephrine by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of phenylephrine. |
| 4292303 |
Polymeric diffusion matrix containing clonidine |
September 29, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of clonidine by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of clonidine. |
| 4292302 |
Polymeric diffusion matrix containing terbutaline |
September 29, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of terbutaline by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of terbutaline. |
| 4292301 |
Polymeric diffusion matrix containing ephedrine |
September 29, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of ephedrine by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharamaceutically effective amount of ephedrine. |
| 4291015 |
Polymeric diffusion matrix containing a vasodilator |
September 22, 1981 |
| A polymeric diffusion matrix containing a vasodilator is provided comprising from about 2 to about 60% of a polar plasticizer, e.g., glycerol, from about 2 to about 15% of a matrix component, e.g., polyvinylalcohol, from about 2 to about 10% of a water-soluble polymer with hydration |
| 4291014 |
Polymeric diffusion matrix containing estradiol diacetate |
September 22, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of estradiol diacetate by delivery to a patient requiring uterine wall maintenance or other types of estrogen therapy wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and |
| 4289749 |
Polymeric diffusion matrix containing phenylpropanolamine |
September 15, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of phenylpropanolamine by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of phenylpropanolami |
